SCHEMBL3845834

SCHEMBL3845834

COc1ccc(C2CCN(c3ncnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)c6ccccc6)c5)cc34)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 8/20 0.47
CYP1A2 P05177 8/20 0.47
CLK4 Q9HAZ1 7/20 0.47
ALDH1A1 P00352 7/20 0.47
CYP2C19 P33261 6/20 0.47
LMNA P02545 5/20 0.47
USP2 O75604 4/20 0.47
HIF1A Q16665 4/20 0.47
CYP2D6 P10635 4/20 0.47
MAPK1 P28482 4/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
TSHR P16473 3/20 0.46
HSD17B10 Q99714 2/20 0.46
MTNR1B P49286 1/20 0.45
HPGD P15428 2/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KIT P10721 3/20 0.43
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846539 0.92 CYP3A4 (0.44) CYP3A4CYP1A2CLK4ALDH1A1CYP2C19
SCHEMBL3847438 0.87 SLC2A1 (0.53) CYP3A4CYP1A2CLK4ALDH1A1CYP2C19
SCHEMBL3845891 0.81 ACHE (0.47) CYP3A4CYP1A2CLK4ALDH1A1CYP2C19
SCHEMBL3852801 0.80 HRH3 (0.44) CYP3A4CYP1A2CLK4ALDH1A1CYP2C19
SCHEMBL3849227 0.80 CHRM4 (0.46) CYP3A4CYP1A2CLK4ALDH1A1CYP2C19
SCHEMBL3846795 0.80 CYP1A2 (0.59) CYP3A4CYP1A2CLK4ALDH1A1CYP2C19
SCHEMBL3847535 0.79 CYP3A4 (0.43) CYP3A4CYP1A2CLK4ALDH1A1CYP2C19
SCHEMBL3848911 0.78 CYP1A2 (0.52) CYP3A4CYP1A2CLK4ALDH1A1CYP2C19
SCHEMBL3847121 0.77 MAPT (0.50) CYP3A4CYP1A2CLK4ALDH1A1CYP2C19
SCHEMBL3846811 0.76 ACHE (0.46) CYP3A4CYP1A2CLK4ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed